awmsg logo

Consultations

AWMSG medicines optimisation guidance documents undergo national consultation prior to endorsement and publication. The following documents are currently under consultation and the views of healthcare professionals, industry representatives and patients/patient groups are welcomed. Please complete the associated pro-forma and return to awttc@wales.nhs.uk.

Please note: Comments received during consultation are compiled in a report and considered by the development group. Each comment will be addressed and any changes to the document that are made as a result will be noted. The summary report including any comments submitted will be available upon request.

AWTTC reserves the right to summarise comments, where it is deemed appropriate, and to not publish comments if we consider their publication to be unlawful or otherwise inappropriate.

By submitting your comments, you are agreeing to them being used in line with the above.

To request a consultation comment summary, please contact: awttc@wales.nhs.uk. Please allow three weeks from the close of the consultation period for the summary to be available.

CEPP National Audit: Antipsychotics in Dementia
This audit has been developed to support local prescribing initiatives as part of the Clinical Effectiveness Prescribing Programme (CEPP), as well as providing a national picture on antipsychotic prescribing in Wales. The aim of this audit is to reduce levels of inappropriate prescribing of antipsychotics in patients aged 65 years and over with a diagnosis of dementia.

CEPP National Audit: Antipsychotics in Dementia - Consultation document
CEPP National Audit: Antipsychotics in Dementia - Consultation pro-forma

Consultation closes: 18 October 2018

Medicines Identified as Low Priority for Funding in NHS Wales - Paper 2
This advice aims to reduce inappropriate variation in prescribing of medicines identified as low priority for funding across NHS Wales. This will ensure that health boards and clinicians are able to make the most efficient use of the resources available to them. This second paper aims to reduce inappropriate variation in prescribing of four medicines/medicine groups in addition to those included in the first Medicines Identified as Low Priority for Funding document published in October 2017.

Medicines Identified as Low Priority for Funding in NHS Wales - Paper 2 - Consultation document
Medicines Identified as Low Priority for Funding in NHS Wales - Paper 2 - Consultation pro-forma

Consultation closes: 19 October 2018